Schwartzbaum et al., who evaluated 277 serum proteins in 487 case–control sets, found that VEGF, beta‐catenin, CCL22, LIF, sIL‐10RB, IL‐4 and sIL‐4Rα were associated with glioma risk.12 The gene discussed is VEGFA; the disease is central nervous system cancer.